| Literature DB >> 29352126 |
Daisuke Koshiyama1, Masaki Fukunaga2, Naohiro Okada1, Fumio Yamashita3, Hidenaga Yamamori4, Yuka Yasuda4, Michiko Fujimoto4, Kazutaka Ohi4, Haruo Fujino5, Yoshiyuki Watanabe6, Kiyoto Kasai7,8, Ryota Hashimoto4,9.
Abstract
Subcortical regions have a pivotal role in cognitive, affective, and social functions in humans, and the structural and functional abnormalities of the regions have been associated with various psychiatric disorders. Although previous studies focused on the neurocognitive and socio-functional consequences of prefrontal and tempolo-limbic abnormalities in psychiatric disorders, those of subcortical structures remain largely unknown. Recently, MRI volume alterations in subcortical structures in patients with schizophrenia have been replicated in large-scale meta-analytic studies. Here we investigated the relationship between volumes of subcortical structures and neurocognitive and socio-functional indices in a large sample of patients with schizophrenia. First, we replicated the results of meta-analyses: the regional volumes of the bilateral hippocampus, amygdala, thalamus and nucleus accumbens were significantly smaller for patients (N = 163) than for healthy controls (HCs, N = 620). Second, in the patient group, the right nucleus accumbens volume was significantly correlated with the Digit Symbol Coding score, which is known as a distinctively characteristic index of cognitive deficits in schizophrenia. Furthermore, the right thalamic volume was significantly correlated with social function scores. In HCs, no significant correlation was found. The results from this large-scale investigation shed light upon the role of specific subcortical nuclei on cognitive and social functioning in schizophrenia.Entities:
Mesh:
Year: 2018 PMID: 29352126 PMCID: PMC5775279 DOI: 10.1038/s41598-017-18950-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and clinical characteristics of participants.
| SZ (N = 163) | HC (N = 620) | Statistics | |||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Effect size, |
| ||
| Age | 35.0 (16–71) | 11.6 | 34.1 (18–66) | 13.0 | 0.07 | 0.42 | |
| Male/Female | 91/72 | 305/315 | χ2 (1.0) = 2.27 | 0.13 | |||
| Education (years) | 14.0 | 2.6 | 15.0 | 2.1 | −0.44 |
| |
| Premorbid IQa | 102.0 | 10.4 | 108.4 | 7.7 | −0.71 |
| |
| Duration of illness (years) | 11.2 | 9.0 | |||||
| PANSS Positiveb | 18.9 | 5.6 | |||||
| PANSS Negativeb | 19.9 | 5.6 | |||||
| PANSS Generalb | 43.3 | 10.5 | |||||
| PANSS Totalb | 82.1 | 19.6 | |||||
| CPZ equivalent (mg/day) | 594.1 | 540.3 | |||||
aSeven patients with schizophrenia and one HC have no premorbid IQ data; bTwo patients with schizophrenia have no PANSS data. Underlining indicates p < 0.05. Age-span was shown in the brackets nearby mean age. Abbreviation: SZ, schizophrenia; HC, healthy control; SD, standard deviation; IQ, intelligence quotient; PANSS, positive and negative syndrome scale; CPZ, chlorpromazine.
Comparison of the MRI indices and cognitive/social indices of interest between patients with schizophrenia and HCs.
| SZ (N = 163) | HC (N = 620) | Statistics | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Effect size, |
| |||
| MRI indices | ||||||||
| Hippocampus | L | 2553.8 | 415.4 | 2783.6 | 339.3 | −0.61 |
| |
| R | 2049.9 | 393.8 | 2258.1 | 324.1 | −0.58 |
| ||
| Amygdala | L | 811.8 | 155.8 | 862.2 | 161.8 | −0.32 |
| |
| R | 987.9 | 198.4 | 1045.1 | 186.6 | −0.30 |
| ||
| Thalamus | L | 2060.3 | 738.9 | 2232.0 | 670.5 | −0.24 |
| |
| R | 1900.6 | 594.8 | 2070.0 | 553.1 | −0.29 |
| ||
| Accumbens | L | 876.6 | 97.3 | 900.4 | 96.7 | −0.24 |
| |
| R | 651.7 | 93.8 | 670.3 | 82.3 | −0.21 |
| ||
| Caudate | L | 2039.4 | 365.8 | 1991.5 | 381.5 | 0.13 | 0.15 | |
| R | 2753.0 | 398.8 | 2656.0 | 399.7 | 0.24 |
| ||
| Putamen | L | 5894.3 | 594.7 | 5759.0 | 572.7 | 0.23 |
| |
| R | 5957.9 | 519.8 | 5742.7 | 504.8 | 0.42 |
| ||
| Pallidum | L | 1383.9 | 221.4 | 1238.2 | 202.8 | 0.69 |
| |
| R | 1205.8 | 171.9 | 1144.3 | 173.5 | 0.36 |
| ||
| Cognitive indices of interest | ||||||||
| Full-Scale IQ | 88.1 | 17.9 | 112.0 | 12.1 | −1.57 |
| ||
| Digit Symbol-Coding | 6.5 | 3.0 | 11.8 | 3.0 | −1.79 |
| ||
| Social indices of interest | ||||||||
| Comprehension | 7.7 | 3.5 | 12.8 | 2.7 | −1.65 |
| ||
| Picture Arrangement | 7.9 | 3.9 | 10.6 | 3.2 | −0.75 |
| ||
| Total score of the UPSA-Ba | 67.8 | 16.8 | 82.9 | 7.8 | −1.16 |
| ||
aOnly 68 patients with schizophrenia and 151 HCs have the UPSA-B data. The unit of MRI indices is mm3. Underlining indicates p < 0.05. Abbreviation: SZ, patients with schizophrenia; HCs, healthy controls; SD, standard deviation; MRI, magnetic resonance imaging; L, left; R, right; IQ, intelligence quotient; UPSA-B, the University of California, San Diego, Performance-Based Skills Assessment Brief.
Figure 1Cohen’s d effect sizes for the difference in MRI indices between patients with schizophrenia and HCs. The vertical axis represents the MRI indices. The horizontal axis represents Cohen’s d effect sizes for the difference in MRI indices between patients with schizophrenia and HCs. Abbreviation: L, left; R, right.
Figure 2Cohen’s d effect sizes for the difference in cognitive/social indices of interest between patients with schizophrenia and HCs. The vertical axis represents cognitive/social indices of interest. The horizontal axis represents Cohen’s d effect sizes for the difference in cognitive/social indices of interest between patients with schizophrenia and HCs. Abbreviation: IQ, intelligence quotient; UPSA-B, the University of California, San Diego, Performance-Based Skills Assessment Brief.
Correlations and partial correlations with adjustment for medication between the MRI indices and cognitive/social indices of interest in patients with schizophrenia.
| Cognitive indices of interest | Social indices of interest | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Full-Scale IQ | Digit Symbol-Coding | Comprehension | Picture Arrangement | Total score of the UPSA | |||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Hippocampus | L | 0.301 |
| 0.211 | 6.9 × 10−3 | 0.230 | 3.1 × 10−3 | 0.175 | 2.6 × 10−2 | 0.247 | 4.3 × 10−2 |
| (0.326) | ( | ||||||||||
| R | 0.301 |
| 0.221 | 4.6 × 10−3 | 0.216 | 5.6 × 10−3 | 0.265 |
| 0.323 | 7.2 × 10−3 | |
| (0.441) | ( | ||||||||||
| Amygdala | L | 0.293 |
| 0.177 | 2.4 × 10−2 | 0.230 | 3.2 × 10−3 | 0.220 | 4.8 × 10−3 | 0.211 | 8.4 × 10−2 |
| (0.370) | ( | ||||||||||
| Thalamus | R | 0.299 |
| 0.219 | 5.0 × 10−3 | 0.296 |
| 0.297 |
| 0.452 |
|
| (0.412) | ( | (0.380) | ( | (0.431) | ( | ||||||
| Accumbens | R | 0.267 |
| 0.266 |
| 0.209 | 7.4 × 10−3 | 0.131 | 9.7 × 10−2 | 0.251 | 3.9 × 10−2 |
| (0.342) | ( | (0.231) | (6.0 × 10−2) | ||||||||
Upper line shows correlations between the MRI indices and cognitive/social indices of interest in patients with schizophrenia. Lower line shows partial correlation between the MRI indices and cognitive/social indices of interest with adjusting for chlorpromazine equivalents for main findings (gray marker of upper line) in patients with schizophrenia. Underlining indicates p < 1.79 × 10−3 (0.05/28) for upper line. Underlining indicates p < 0.05 for lower line. Abbreviations: IQ, intelligence quotient; UPSA-B, the University of California, San Diego, Performance-Based Skills Assessment Brief; L, left; R, right.